Kenai Therapeutics Opens Research Facility At Lilly Gateway Labs
12 Feb 2025 //
BUSINESSWIRE
Kenai Therapeutics Establishes Patient Advisory Board
14 Nov 2024 //
BUSINESSWIRE
Kenai Therapeutics Appoints Dr. Derek Hei as CTO
23 Oct 2024 //
BUSINESSWIRE
Kenai Therapeutics Announces $82 Million Series A Financing
29 Feb 2024 //
BUSINESSWIRE